MEDICLINIC INTERNATIONAL PLC - Transactions by persons discharging managerial responsibilities and persons closely associated with them

Release Date: 10/08/2018 15:00
Code(s): MEI
 
Wrap Text
Transactions by persons discharging managerial responsibilities and persons closely associated with them

Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
(“Mediclinic”, the “Company” or the “Group”)

10 August 2018

NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

On 8 August 2018, Mr Jurgens Myburgh, Chief Financial Officer of Mediclinic International plc,
acquired 20,000 shares in the Company at ZAR 86.82 per share. Accordingly, Mr Myburgh now owns
a total of 80,000 shares in Mediclinic International plc.

The following notification is made in accordance with Articles 19.1 and 19.3 of the Market Abuse
Regulation.

1.     Details of PDMR / persons closely associated with them (“PCA”)
a)     Name                     Mr Petrus Jurgens Myburgh

2.     Reason for the notification
a)     Position / status        Chief Financial Officer of the Company
b)     Initial notification /   Initial Notification
       amendment

3.     Details of the issuer, emission allowance market participant, auction platform, auctioneer or
       auction monitor
a)     Name                     Mediclinic International plc
b)     LEI                      2138002S5BSBIZTD5I60

4.     Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each
       type of transaction; (iii) each date; and (iv) each place where transactions have been
       conducted
a)     Description of the       Ordinary Shares
       financial instrument
       Identification Code      GB00B8HX8Z88
b)     Nature of the            Purchase of shares
       transaction
c)     Price(s) and
       volume(s)                Price(s)                           Volume(s)
                                ZAR 86.82 per share                20 000
d)     Aggregated
       information
       Aggregated volume        20 000
       Price                    ZAR 86.82
e)     Date of the              8 August 2018; 14:21 UTC
       transaction
f)     Place of the             Johannesburg Stock Exchange
       transaction

About Mediclinic International plc

Mediclinic is an international private healthcare services group with operating divisions in Switzerland,
Southern Africa (South Africa and Namibia) and the United Arab Emirates. Its core purpose is to
enhance the quality of life of patients by providing acute care, specialist-orientated, multi-disciplinary
healthcare services. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, an LSE-
listed and UK-based private healthcare group.

Mediclinic comprises 74 hospitals and 30 clinics. Hirslanden operates 17 private acute care facilities
and 4 clinics in Switzerland with more than 1 800 inpatient beds; Mediclinic Southern Africa operates
48 hospitals and 2 day clinics throughout South Africa and 3 hospitals in Namibia with more than 8
100 inpatient beds in total; and Mediclinic Middle East operates 6 hospitals and 24 clinics with more
than 700 inpatient beds in the United Arab Emirates.

Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary
listings on the JSE in South Africa and the NSX in Namibia.

For further information, please contact:

Company Secretary, Link Company Matters Limited
Jayne Meacham / Caroline Emmet
+44 (0)20 7954 9569

Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181

Media queries
FTI Consulting
Brett Pollard/Debbie Scott – UK
+44 (0)20 3727 1000
Sherryn Schooling – South Africa
+27 (0)21 487 9000

Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom
Website: www.mediclinic.com
Joint corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
Date: 10/08/2018 03:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Email this JSE Sens Item to a Friend.

Share This Story